NDAOralTablet
Approved
Jun 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 8h ago · AI intelligence enriched 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PREMPRO/PREMPHASE is an oral combination hormone replacement therapy (HRT) containing conjugated estrogens and medroxyprogesterone acetate, indicated for managing menopausal symptoms and osteoporosis prevention. It replaces declining estrogen and progesterone levels in postmenopausal women to alleviate vasomotor symptoms and vaginal atrophy. The product comes in a cyclic (PREMPHASE) or continuous (PREMPRO) dosing regimen tailored to individual patient needs.
LOE Approaching
Product faces moderate competitive pressure (30/100) with approaching loss of exclusivity, signaling smaller team size and focus on retention strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PREMPRO/PREMPHASE offers experience in managing a legacy product through loss of exclusivity and competitive erosion, with emphasis on market access, patient advocacy, and navigating complex safety/efficacy messaging around HRT. Career growth is limited by the product's maturity, making this role best suited for professionals developing expertise in lifecycle management and defending established brands in crowded markets.
Brand Manager
Worked on PREMPRO/PREMPHASE at Thayer Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.